INMB
Price
$2.53
Change
+$0.17 (+7.20%)
Updated
Jul 3 closing price
Capitalization
68.92M
24 days until earnings call
PROK
Price
$0.64
Change
+$0.06 (+10.34%)
Updated
Jul 3 closing price
Capitalization
82.54M
31 days until earnings call
Interact to see
Advertisement

INMB vs PROK

Header iconINMB vs PROK Comparison
Open Charts INMB vs PROKBanner chart's image
INmune Bio
Price$2.53
Change+$0.17 (+7.20%)
Volume$4.7M
Capitalization68.92M
ProKidney
Price$0.64
Change+$0.06 (+10.34%)
Volume$1.54M
Capitalization82.54M
INMB vs PROK Comparison Chart in %
Loading...
INMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INMB vs. PROK commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INMB is a Hold and PROK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (INMB: $2.53 vs. PROK: $0.64)
Brand notoriety: INMB and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INMB: 156% vs. PROK: 145%
Market capitalization -- INMB: $68.92M vs. PROK: $82.54M
INMB [@Biotechnology] is valued at $68.92M. PROK’s [@Biotechnology] market capitalization is $82.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INMB’s FA Score shows that 0 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • INMB’s FA Score: 0 green, 5 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, PROK is a better buy in the long-term than INMB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INMB’s TA Score shows that 5 TA indicator(s) are bullish while PROK’s TA Score has 3 bullish TA indicator(s).

  • INMB’s TA Score: 5 bullish, 5 bearish.
  • PROK’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, INMB is a better buy in the short-term than PROK.

Price Growth

INMB (@Biotechnology) experienced а -59.71% price change this week, while PROK (@Biotechnology) price change was -11.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

INMB is expected to report earnings on Jul 30, 2025.

PROK is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PROK($82.5M) has a higher market cap than INMB($68.9M). INMB YTD gains are higher at: -45.824 vs. PROK (-62.296). INMB has higher annual earnings (EBITDA): -41.52M vs. PROK (-160.12M). PROK has more cash in the bank: 328M vs. INMB (19.3M). INMB has less debt than PROK: INMB (347K) vs PROK (3.37M). PROK has higher revenues than INMB: PROK (306K) vs INMB (50K).
INMBPROKINMB / PROK
Capitalization68.9M82.5M84%
EBITDA-41.52M-160.12M26%
Gain YTD-45.824-62.29674%
P/E RatioN/AN/A-
Revenue50K306K16%
Total Cash19.3M328M6%
Total Debt347K3.37M10%
FUNDAMENTALS RATINGS
INMB: Fundamental Ratings
INMB
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INMBPROK
RSI
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
69%
Momentum
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
65%
MACD
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
72%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
72%
Declines
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 7 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
52%
Aroon
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
INMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHEAF0.36N/A
N/A
China Eastern Airlines Corp. Ltd.
AINSF0.56N/A
N/A
Ainsworth Game Technology Ltd.
CBULF0.09N/A
N/A
Gratomic Inc.
CNTHP52.10N/A
N/A
Connecticut Light & Power Co. (The)
SRAIF23.23N/A
N/A
STADLER RAIL AG

INMB and

Correlation & Price change

A.I.dvisor indicates that over the last year, INMB has been loosely correlated with UBX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if INMB jumps, then UBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INMB
1D Price
Change %
INMB100%
+7.20%
UBX - INMB
55%
Loosely correlated
-1.71%
ABCL - INMB
46%
Loosely correlated
+1.33%
GBIO - INMB
36%
Loosely correlated
+1.51%
PROK - INMB
36%
Loosely correlated
+10.11%
OVID - INMB
35%
Loosely correlated
+2.39%
More

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with RXRX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
+10.11%
RXRX - PROK
49%
Loosely correlated
+1.15%
NAUT - PROK
43%
Loosely correlated
+4.73%
ARCT - PROK
43%
Loosely correlated
+1.17%
IMNM - PROK
42%
Loosely correlated
+2.43%
BEAM - PROK
42%
Loosely correlated
+0.65%
More